vs

Side-by-side financial comparison of Akamai Technologies (AKAM) and CME Group (CME). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.1B, roughly 1.7× Akamai Technologies). Akamai Technologies runs the higher net margin — 7.8% vs 0.1%, a 7.7% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 7.4%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs 5.3%).

Akamai Technologies, Inc. provides cloud services for securing, delivering, and optimizing content and business applications over the internet in the United States and internationally. The company offers cloud solutions to keep infrastructure, websites, applications, application programming interfaces, and users safe from various cyberattacks and online threats while enhancing performance. It also provides web and mobile performance solutions to enable dynamic websites and applications; media...

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

AKAM vs CME — Head-to-Head

Bigger by revenue
CME
CME
1.7× larger
CME
$1.9B
$1.1B
AKAM
Growing faster (revenue YoY)
CME
CME
+7.1% gap
CME
14.5%
7.4%
AKAM
Higher net margin
AKAM
AKAM
7.7% more per $
AKAM
7.8%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
5.3%
AKAM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AKAM
AKAM
CME
CME
Revenue
$1.1B
$1.9B
Net Profit
$85.1M
$1.2M
Gross Margin
58.7%
Operating Margin
8.7%
0.1%
Net Margin
7.8%
0.1%
Revenue YoY
7.4%
14.5%
Net Profit YoY
-39.2%
20.7%
EPS (diluted)
$0.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AKAM
AKAM
CME
CME
Q1 26
$1.9B
Q4 25
$1.1B
$1.6B
Q3 25
$1.1B
$1.5B
Q2 25
$1.0B
$1.7B
Q1 25
$1.0B
$1.6B
Q4 24
$1.0B
$1.5B
Q3 24
$1.0B
$1.6B
Q2 24
$979.6M
$1.5B
Net Profit
AKAM
AKAM
CME
CME
Q1 26
$1.2M
Q4 25
$85.1M
$1.2B
Q3 25
$140.2M
$908.0M
Q2 25
$103.6M
$1.0B
Q1 25
$123.2M
$956.2M
Q4 24
$139.9M
$874.6M
Q3 24
$57.9M
$912.8M
Q2 24
$131.7M
$883.2M
Gross Margin
AKAM
AKAM
CME
CME
Q1 26
Q4 25
58.7%
Q3 25
59.3%
Q2 25
59.1%
Q1 25
58.7%
Q4 24
59.4%
Q3 24
59.3%
Q2 24
58.9%
Operating Margin
AKAM
AKAM
CME
CME
Q1 26
0.1%
Q4 25
8.7%
61.8%
Q3 25
15.7%
63.3%
Q2 25
14.5%
66.7%
Q1 25
15.2%
67.5%
Q4 24
14.5%
62.1%
Q3 24
7.0%
64.6%
Q2 24
15.1%
65.3%
Net Margin
AKAM
AKAM
CME
CME
Q1 26
0.1%
Q4 25
7.8%
71.7%
Q3 25
13.3%
59.1%
Q2 25
9.9%
60.6%
Q1 25
12.1%
58.2%
Q4 24
13.7%
57.3%
Q3 24
5.8%
57.6%
Q2 24
13.4%
57.6%
EPS (diluted)
AKAM
AKAM
CME
CME
Q1 26
Q4 25
$0.57
$3.24
Q3 25
$0.97
$2.49
Q2 25
$0.71
$2.81
Q1 25
$0.82
$2.62
Q4 24
$0.92
$2.40
Q3 24
$0.38
$2.50
Q2 24
$0.86
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AKAM
AKAM
CME
CME
Cash + ST InvestmentsLiquidity on hand
$1.2B
$2.4B
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$5.0B
Total Assets
$11.5B
$202.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AKAM
AKAM
CME
CME
Q1 26
$2.4B
Q4 25
$1.2B
$4.5B
Q3 25
$1.1B
$2.6B
Q2 25
$966.6M
$2.1B
Q1 25
$1.3B
$1.5B
Q4 24
$1.6B
$3.0B
Q3 24
$1.7B
$2.4B
Q2 24
$1.6B
$1.9B
Total Debt
AKAM
AKAM
CME
CME
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
AKAM
AKAM
CME
CME
Q1 26
Q4 25
$5.0B
$28.7B
Q3 25
$4.7B
$28.2B
Q2 25
$4.5B
$27.7B
Q1 25
$4.6B
$27.0B
Q4 24
$4.9B
$26.5B
Q3 24
$4.8B
$28.2B
Q2 24
$4.8B
$27.6B
Total Assets
AKAM
AKAM
CME
CME
Q1 26
$202.0B
Q4 25
$11.5B
$198.4B
Q3 25
$10.8B
$187.1B
Q2 25
$10.5B
$179.9B
Q1 25
$10.0B
$157.8B
Q4 24
$10.4B
$137.4B
Q3 24
$10.2B
$137.8B
Q2 24
$10.1B
$123.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AKAM
AKAM
CME
CME
Operating Cash FlowLast quarter
$366.6M
Free Cash FlowOCF − Capex
$234.9M
FCF MarginFCF / Revenue
21.5%
Capex IntensityCapex / Revenue
12.0%
Cash ConversionOCF / Net Profit
4.31×
TTM Free Cash FlowTrailing 4 quarters
$1.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AKAM
AKAM
CME
CME
Q1 26
Q4 25
$366.6M
$1.1B
Q3 25
$441.8M
$968.1M
Q2 25
$459.1M
$1.1B
Q1 25
$251.2M
$1.1B
Q4 24
$343.8M
$1.0B
Q3 24
$392.5M
$1.0B
Q2 24
$431.0M
$776.9M
Free Cash Flow
AKAM
AKAM
CME
CME
Q1 26
Q4 25
$234.9M
$1.1B
Q3 25
$329.1M
$949.7M
Q2 25
$313.6M
$1.0B
Q1 25
$133.4M
$1.1B
Q4 24
$250.9M
$991.7M
Q3 24
$279.7M
$973.2M
Q2 24
$340.0M
$758.7M
FCF Margin
AKAM
AKAM
CME
CME
Q1 26
Q4 25
21.5%
66.8%
Q3 25
31.2%
61.8%
Q2 25
30.1%
61.5%
Q1 25
13.1%
67.1%
Q4 24
24.6%
65.0%
Q3 24
27.8%
61.4%
Q2 24
34.7%
49.5%
Capex Intensity
AKAM
AKAM
CME
CME
Q1 26
Q4 25
12.0%
2.0%
Q3 25
10.7%
1.2%
Q2 25
13.9%
1.1%
Q1 25
11.6%
0.9%
Q4 24
9.1%
1.7%
Q3 24
11.2%
1.9%
Q2 24
9.3%
1.2%
Cash Conversion
AKAM
AKAM
CME
CME
Q1 26
Q4 25
4.31×
0.96×
Q3 25
3.15×
1.07×
Q2 25
4.43×
1.03×
Q1 25
2.04×
1.17×
Q4 24
2.46×
1.16×
Q3 24
6.78×
1.10×
Q2 24
3.27×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AKAM
AKAM

Security$592.4M54%
Delivery$311.1M28%
Cloud Computing$191.4M17%

CME
CME

Segment breakdown not available.

Related Comparisons